跳至主要内容
临床试验/NCT03405584
NCT03405584已完成4 期

Efficacy of High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment:a Randomized Clinical Trial

Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2018年1月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
160
试验地点
1
主要终点
Helicobacter pylori eradication rate

研究概览

简要总结

Dual therapy for Helicobacter Pylori including a proton pump inhibitor (PPI) and amoxicillin. Amoxicillin has low resistance rate as well as low percentage of side effects. No trial has examined the the efficacy of high dose of dual therapy plus bismuth for H. pylori treatment.This study is designed to evaluate the efficacy and safety of the addition of bismuth to high dose of dual therapy for H. pylori eradication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants with non-ulcer functional dyspepsia or peptic ulcer disease
  • Ability and willingness to participate in the study and to sign and give informed consent
  • Confirmed H. pylori infection

排除标准

  • Less than 18 years old
  • With previous gastric surgery
  • Major systemic diseases
  • Pregnancy or lactation
  • Allergy to any of the study drugs Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion

研究组 & 干预措施

Bismuth Plus Dual Therapy

Experimental

Esomeprazole 40mg bid, Amoxicillin 1.0g tid and Bismuth Potassium Citrate 600mg bid for 14 days.

干预措施: Esomeprazole (Drug)

Bismuth Plus Dual Therapy

Experimental

Esomeprazole 40mg bid, Amoxicillin 1.0g tid and Bismuth Potassium Citrate 600mg bid for 14 days.

干预措施: Amoxicillin (Drug)

Bismuth Plus Dual Therapy

Experimental

Esomeprazole 40mg bid, Amoxicillin 1.0g tid and Bismuth Potassium Citrate 600mg bid for 14 days.

干预措施: Bismuth Potassium Citrate (Drug)

Dual Therapy

Active Comparator

Esomeprazole 40mg bid and Amoxicillin 1.0g tid for 14 days.

干预措施: Esomeprazole (Drug)

Dual Therapy

Active Comparator

Esomeprazole 40mg bid and Amoxicillin 1.0g tid for 14 days.

干预措施: Amoxicillin (Drug)

结局指标

主要结局

Helicobacter pylori eradication rate

时间窗: Six weeks after completion of therapy

Six weeks after completion of therapy, H. pylori eradication was assessed by ¹³C-urea breath test. Eradication was defined as negative result from urea breath test (\<4‰) (4‰ as the cutoff value).

次要结局

  • Rate of adverse effects(Within 7 days after completion of therapy.)
  • Compliance rate(Within 7 days after completion of therapy.)

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Lu, MD

Medical Doctor of Division of Gastroenterology and Hepatology of Renji Hospital,Professor of Medicine

Shanghai Jiao Tong University School of Medicine

研究点 (1)

Loading locations...

相似试验